These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26133772)

  • 1. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
    Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y
    Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
    Zhao M; Yang F; Sang C; Yan C; Wang Z
    J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of long non-coding RNA LINC00982 suppresses cell proliferation and tumor growth of papillary thyroid carcinoma through PI3K-ATK signaling pathway.
    Xu D; Yu J; Zhuang S; Zhang S; Hong Z; Yuan C
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers.
    Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
    Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
    Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic Acid Receptor 5 (LPAR5) Plays a Significance Role in Papillary Thyroid Cancer via Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin (mTOR) Pathway.
    Wu CY; Zheng C; Xia EJ; Quan RD; Hu J; Zhang XH; Hao RT
    Med Sci Monit; 2020 Jan; 26():e919820. PubMed ID: 31902939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the PIK3CA gene expression level in FNAB washouts equivalent to that in postoperative tissue specimens of papillary thyroid carcinoma?
    Wojciechowska-Durczynska K; Krawczyk-Rusiecka K; Cyniak-Magierska A; Zygmunt A; Dedecjus M; Lewinski A
    Neuro Endocrinol Lett; 2011; 32(1):59-63. PubMed ID: 21407159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
    Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
    Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of Long Non-coding RNA ENST00000606790.1 Inhibits the Malignant Behaviors of Papillary Thyroid Carcinoma through the PI3K/AKT Pathway.
    Zuo Z; Liu L; Song B; Tan J; Ding D; Lu Y
    Endocr Res; 2021 Feb; 46(1):1-9. PubMed ID: 32791924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
    Zhang H; Hu N
    Mol Med Rep; 2018 Aug; 18(2):1345-1352. PubMed ID: 29901196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer.
    Sun W; Lan X; Wang Z; Dong W; He L; Zhang T; Zhang H
    Med Oncol; 2016 Sep; 33(9):102. PubMed ID: 27510368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase/AKT signaling pathway in thyroid tumors.
    Hou P; Ji M; Xing M
    Cancer; 2008 Nov; 113(9):2440-7. PubMed ID: 18831514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma.
    Uddin S; Bavi P; Siraj AK; Ahmed M; Al-Rasheed M; Hussain AR; Ahmed M; Amin T; Alzahrani A; Al-Dayel F; Abubaker J; Bu R; Al-Kuraya KS
    Endocr Relat Cancer; 2010 Mar; 17(1):191-202. PubMed ID: 20008098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.